Castleark Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,890
Closed -$4.55M 282
2023
Q3
$4.55M Sell
27,890
-5,140
-16% -$904K 0.23% 109
2023
Q2
$6.06M Sell
33,030
-320
-1% -$46.1K 0.27% 82
2023
Q1
$4.44M Hold
33,350
0.22% 111
2022
Q4
$2.65M Buy
33,350
+520
+2% +$36.6K 0.14% 150
2022
Q3
$1.99M Sell
32,830
-48,720
-60% -$3.15M 0.11% 151
2022
Q2
$4.47M Buy
81,550
+37,570
+85% +$2.18M 0.24% 106
2022
Q1
$3.32M Buy
+43,980
New +$3M 0.14% 148

Other funds holding ACLS

Castleark Management's ACLS Position: Q4 2023 in Review

Castleark Management sold out of Axcelis (ACLS) in Q4 2023, closing a stake of 27,890 shares — an estimated $4.55M sold.

Castleark Management first reported a position in ACLS in Q1 2022 and held it in 7 quarters. The position peaked at $6.06M in Q2 2023. 421 funds tracked by Wall St. Rank hold ACLS as of Q4 2023.

  • Castleark Management reported no remaining Axcelis position as of Q4 2023 after selling out during the quarter.
  • Castleark Management sold 27,890 Axcelis shares in Q4 2023, an estimated $4.55M.
  • Castleark Management first reported a position in Axcelis in Q1 2022 and held it in 7 quarters.
  • Castleark Management's Axcelis position peaked at $6.06M in Q2 2023.
  • 421 funds tracked by Wall St. Rank held Axcelis as of Q4 2023.

Based on Castleark Management's 13F filing for Q4 2023, filed 15 Feb 2024.